Medicare P&T Committees Draw Attention Of Justice Department
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharmacy & therapeutics committee members may be targets of corruption by pharma companies because they make binding decisions about placement on a Medicare plan’s formulary, Boston federal prosecutor Loucks says. Manufacturers are advised to keep Medicare, commercial formulary negotiations separate.